Simulated Assessment of Pharmacokinetically Guided Dosing for Investigational Treatments of Pediatric Patients With Coronavirus Disease 2019
Anil R. Maharaj(Clinical Research Institute), Michael Cohen‐Wolkowiez(Duke University), Huali Wu(Duke University), Kanecia O. Zimmerman(Duke University), Stephen J. Balevic(Duke University), Daniel González(University of North Carolina at Chapel Hill), Daniel K. Benjamin(Duke University), Christoph P. Hornik(Duke University), P. Brian Smith(Duke University), Chi D. Hornik
Cited by 47
Related Papers
Clinical Practice Guidelines for the Management Candidiasis: 2009 Update by the Infectious Diseases Society of America
|Clinical Infectious Diseases|2009|3.2k
Significance of Protein Binding in Pharmacokinetics and Pharmacodynamics
|Journal of Pharmaceutical Sciences|2009|337
A Randomized, Double-blind, Multicenter Trial Comparing Efficacy and Safety of Imipenem/Cilastatin/Relebactam Versus Piperacillin/Tazobactam in Adults With Hospital-acquired or Ventilator-associated Bacterial Pneumonia (RESTORE-IMI 2 Study)
|Clinical Infectious Diseases|2020|232